Mutations of the AML1 gene are frequent molecular abnormalities in minimally differentiated acute myeloblastic leukemia (MO AML), a rare type of AML. In this retrospective multicenter study, morphologic, immunophenotypical, cytogenetic, and molecular features of 59 de novo MO AML cases were analyzed and correlated to AML1 mutations. Point mutations AML1 gene were observed in 16 cases (27%). They were correlated with higher white blood cell (WBC) count (P = .001), greater marrow blast involvement (P = .03), higher incidence of immunoglobulin H/T-cell receptor (IgH/TCR) gene rearrangement (P < .0001), and with a borderline significant lower incidence of complex karyotypes. In the 59 patients, FLT3 mutations were the only significant prognostic factors associated with short survival. 0 (C) 2003 by The American Society of Hematology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据